Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Solentim Ltd
Solentim Ltd
Activities:
Analysis
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Finance
Cell-based therapy specialist Solentim expands European operations
The England-based company has established a new EU entity based in Ireland to facilitate frictionless business within the EU
Finance
Solentim expands operations to China
“This direct investment will help us support and expand our activities,” said General Manager of Solentim China, Kun Peng
Research & Development
Solentim launches workflow for single stem cell cloning
The company aims to create, isolate and characterise the highest value cells for biological medicine development
Manufacturing
Solentim names new Chief Marketing Officer
Dr Mark Truesdale will join the cell line development (CLD) instrumentation specialist
Pharmaceutical
Solentim and SAL Scientific partner on cell line development
Collaboration will add SAL’s new growth supplements for cell culture media to Solentim's offerings
Finance
Research funding round-up
Capital to support the development of new drugs and technology around the world
Manufacturing
Simple, single-use TFF solution for R&D or manufacturing
Solentim claims significant time-saving advantages are provided by its new systems
Subscribe now